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morning stiffness), BASFI, ASQoL and the SF-36. Literature review, and clinician 
and patient interviews, provided information on instrument content validity. 
Statistical analysis of measurement properties evaluated the reliability (test-
retest and internal consistency), responsiveness and construct validity. 
Measurement properties were assessed using data from the RAPID-axSpA trial 
investigating certolizumab pegol (CZP) efficacy in axSpA. RESULTS: Reviewed AS 
literature revealed relevant concepts: physical function, pain, disease activity, 
morning stiffness, fatigue, disturbed sleep, depression, mobility problems, 
problems performing recreational activities/household tasks/self-care/work, and 
problems socializing. The same concepts were evident for the overall axSpA 
population in expert interviews. Concepts identified in patient interviews were 
consonant with both literature and expert opinion. All PRO instruments were 
satisfactorily reliable in the RAPID-axSpA population, with all test-retest intra-
class correlation coefficients and internal consistency Cronbach’s alphas >0.8. 
Validity was supported by agreement between PRO and clinician-rated 
measures. All the PRO measures showed good sensitivity to change, with large 
response sizes (effect size >0.8) on almost all measures from week 12 in RAPID-
axSpA. No significant variations in psychometric properties were noted between 
axSpA sub-populations. CONCLUSIONS: This study indicates that both the 
content validity and the measurement properties of PRO instruments used in AS 
are preserved in the broad axSpA population. Questions remain about relying on 
classical test theory for validation and the value of using generic outcome 
measures when well-developed disease-specific measures are available.  
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OBJECTIVES: Lead-time time trade-off (TTO) is a promising alternative to 
conventional TTO. The purpose of this study was to compare the values of EQ-
5D-5L health states as measured by two TTO variants using different ratios of 
lead time to unhealthy time. METHODS: Data were collected as part of a wider 
multi-country pilot study. We elicited the values of 10 selected EQ-5D-5L health 
states from a convenience general population sample (N=406) using two lead-
time TTO variants: 10 years of lead time in full health preceding 5 years of 
unhealthy time (standard method), and 5 years of lead time preceding 5 years of 
unhealthy time (experimental method). Participants self-completed the tasks 
using personal computers, with an interviewer supervising groups of 
participants. Participants were randomized to receive one of the two TTO 
variants to value a block of 5 EQ-5D-5L states. The TTO values were compared 
between the two study arms using random-effects linear models, with 
adjustment of age, gender, education, and health states. RESULTS: Health-state 
values generated from TTO valuation exercises using the longer lead time were 
slightly lower than those generated from exercises using the shorter lead time. 
The proportion of non-negative values in the standard and experimental arms 
was 81.2% and 86.7%, respectively (p=0.046); the grand mean TTO value was 0.35 
and 0.43 for the standard and experimental arms, respectively (p=0.049). 
Exhaustion of tradable time occurred only in the experimental arm (0.46%) 
where the lead time was shorter. CONCLUSIONS: This study confirms earlier 
findings that the ratio of lead time to time in poor health exerts an effect on TTO 
values of health states. The more lead time is offered, the more time is traded. 
Different lead-time TTO variants should be carefully studied in order to achieve 
the best measurement of health-state values using this new method.  
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OBJECTIVES: Time preferences and discounting has become indoctrinated in the 
evaluation of health care technologies that generate future benefits and costs. 
Moreover, it remains a fundamental economic concept that is relied upon for the 
understanding of individuals’ decision making with respect to health. The aim of 
this paper is to provide a systematic review of the empirical studies that have 
attempted to measure either individual or societal inter-temporal preferences 
regarding health. METHODS: A systematic search of peer-reviewed articles 
published in English during 1980 to 2012. The Preferred Reporting System for 
Systematic Reviews and Meta-Analysis (PRISMA) strategy was followed to ensure 
systematic selection of the papers. Articles were excluded if they did not report a 
discount rate or factor(s); and if health (and or life years) was not the domain for 
which discount estimates were provided. Two reviewers assessed the results of 
the search against a predefined exclusion and inclusion strategy to ensure 
appropriate inclusion of papers. RESULTS: A total 64 studies were identified 
within 54 published articles. A variety of methodological approaches have been 
implemented to measure preferences as well as testing over a variety of 
functional forms including hyperbolic and quasi-hyperbolic models. Estimates 
for a constant discount rate vary significantly from below zero to over 1000%. 
However, a weight of evidence in support of hyperbolic or at least non-constant 
discounting is emerging. Evidence is equivocal at best with regards to the 
relationship between time preferences measured and health behaviors. 
CONCLUSIONS: It has become common practice, and is often advised, that 
economic models of future costs and consequences should conduct sensitivity 
analyses regarding the discount rate chosen. From the empirical evidence it 
appears as important that such models also consider the sensitivity of models to 
other debatable concepts regarding discounting including the use of hyperbolic 
functions.  
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OBJECTIVES: Optimizing the clinical trial design and establishing the appropriate 
populations early in development are essential to substantiating a compelling 
value proposition. This project sought to provide an example of how a 
subpopulation investigation can inform early development strategy. METHODS: 
US 2012 National Health and Wellness Survey data were used. Respondents with 
pain in the past month were included. The distribution of work productivity 
(using the WPAI questionnaire) was examined and subpopulations of pain 
patients with particularly high or low impairment were described and compared 
to uncover groups with the highest likelihood of showing incremental benefit 
substantial enough to demonstrate value and compel funding. RESULTS: A total 
of 24,215 respondents (34.0%) reported pain in the past month (mean age=49.96; 
51.92% were female). Mean level of pain severity in the last week was 4.71 
(SD=2.72) and mean overall work productivity loss was 22.04% (SD=27.84%). 
Although these variables were significantly related (r=0.45, p<0.05), a substantial 
percentage of people with pain reported no work impairment (44.23%) creating a 
floor effect whereby regardless of the improvement in pain, no effect would be 
observed with respect to the ability to work. Conversely, 3.6% of people with pain 
reported 90% or more of their work week being impaired. Few demographic 
differences (age, sex) were observed between these two extremes, though those 
with 90%+ impairment were more likely to be obese (43.40%) versus those 
without any impairment (32.80%). CONCLUSIONS: Pain severity and work 
productivity loss were significantly related but many of those with pain reported 
so little impairment that no intervention could provide a compelling proposition. 
However, key subgroups (e.g. those obese) reported significant impairments with 
a much greater likelihood of demonstrating treatment benefit. Subgroup analysis 
early in development can identify the most relevant patient populations and 
help inform clinical trial design, optimize incremental value, and drive cost 
effectiveness.  
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OBJECTIVES: The Rey Auditory Verbal Learning Test (RAVLT) is a cognitive test 
assessing verbal learning and memory. Fifteen words (List A) are presented 
across five learning trials and queried during two delayed-recall trials. A second 
15-word list (List B) designed to interfere with recollection of the primary list is 
used. A recognition trial is administered during which subjects are asked to 
detect List A words from amidst distractor words from List B plus 20 others that 
have a semantic and/or a phonetic link with words from the lists. The objective 
of this abstract is to present the translation process of the RAVLT into Japanese. 
METHODS: For the 30 words from the two lists a direct translation was 
recommended based on collaborative efforts involving a speech therapist and a 
neuropsychologist. The goal was to maintain similar frequency of use and 
syllables (±1 syllable or ±2 syllables and ±2 characters) to the source English 
terms. For the 20 additional words used in the recognition trial, the translations 
had to respect the semantic and/or phonetic links to the words from the two 
lists. RESULTS: Discussions ensued around six of the 30 words from the lists due 
to difficulties in finding direct translations with the appropriate number of 
syllables. For the recognition words, the most problematic issue was finding 
equivalents maintaining the phonetic link to the Japanese translation. Ten 
recognition words had to be changed to uphold this linguistic property. For 
instance, the recognition word “Tree” required a phonetic link to the recall word 
“Turkey” so it was translated as “Box” (Ha Ko) to preserve the phonetic link with 
the word chosen to replace “Turkey” (i.e., “Pigeon” (Ha To)). CONCLUSIONS: This 
methodology enabled the production of a Japanese version of the RAVLT that 
preserved the intent and integrity of the source US English test.  
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OBJECTIVES: According to PhRMA, 75% of Americans are non-adherent on one or 
more of their medications. Low adherence leads to worsening of the disease and 
unnecessary health care spending. Various tools have been used by health care 
professionals to improve medication adherence. The objective of this study is to 
conduct a systematic review to identify tools used to improve medication 
adherence and their impact on medication adherence. METHODS: PRISMA 
guidelines were followed for conducting a systematic review. A comprehensive 
electronic search of research databases (PubMed, MEDLINE, EBSCO, and 
PsycINFO), was performed. Combinations of search terms were generated by 
reviewing existing literature and consulting an expert librarian. Search terms 
included the names of each tool, adherence, compliance, persistence, and 
medication adherence. Studies were included if they were conducted after 
January 2000; involved the use of an adherence tool recommended by a certified 
health care professional; and measured the rate of medication adherence as an 
outcome. Studies on measuring adherence to vaccines and lifestyle 
modifications were excluded. RESULTS: Preliminary search yielded 637 articles. 
Articles were excluded following a title review (552) and an abstract review (43). 
Forty-two studies met the criteria for full review. Six different adherence tools 
